Morgan Stanley resumed coverage of Illumina (ILMN) with an Equal Weight rating and $156 price target While the firm views the move higher as “justified” after GRAIL resolution, framing achievable long-term targets and an efficiency push, it sees the stock as range-bound pending evidence of a sustained top-line reacceleration, the analyst tells investors.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina price target raised to $184 from $170 at Stephens
- Illumina price target lowered to $185 from $195 at Piper Sandler
- Illumina price target raised to $139 from $124 at Baird
- Illumina price target raised to $254 from $252 at RBC Capital
- Illumina price target raised to $177 from $166 at TD Cowen